.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Bisoprolol fumarate; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard
Bisoprolol fumarate; hydrochlorothiazide is the generic ingredient in two branded drugs marketed by Unichem, Sandoz, Ivax Sub Teva Pharms, Apothecon, Mylan, Watson Labs, Actavis Elizabeth, Teva, and Teva Womens, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for bisoprolol fumarate; hydrochlorothiazide. Eleven suppliers are listed for this compound.

Summary for Generic Name: bisoprolol fumarate; hydrochlorothiazide

Tradenames:2
Patents:0
Applicants:9
NDAs:10
Drug Master File Entries: see list12
Suppliers / Packaging: see list11
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: bisoprolol fumarate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
bisoprolol fumarate; hydrochlorothiazide
TABLET;ORAL075768-003Sep 25, 2000RXNo► subscribe► subscribe
Actavis Elizabeth
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
bisoprolol fumarate; hydrochlorothiazide
TABLET;ORAL075672-003Sep 25, 2000DISCNNo► subscribe► subscribe
Ivax Sub Teva Pharms
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
bisoprolol fumarate; hydrochlorothiazide
TABLET;ORAL075632-002Sep 27, 2000DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bisoprolol fumarate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Womens
ZIAC
bisoprolol fumarate; hydrochlorothiazide
TABLET;ORAL020186-001Mar 26, 19934,258,062*PED► subscribe
Teva Womens
ZIAC
bisoprolol fumarate; hydrochlorothiazide
TABLET;ORAL020186-003Mar 26, 19934,358,062*PED► subscribe
Teva Womens
ZIAC
bisoprolol fumarate; hydrochlorothiazide
TABLET;ORAL020186-003Mar 26, 19934,258,062► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc